Immediate Impact

18 standout
Sub-graph 1 of 9

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Pathogenesis of allergic diseases and implications for therapeutic interventions
2023 Standout
3 intermediate papers

Works of Britt Jensen being referenced

Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
2017

Author Peers

Author Last Decade Papers Cites
Britt Jensen 19 17 41 65 64 5 162
Peter Maisel 10 2 110 16 81 8 243
Nowrin U. Chowdhury 5 16 5 51 18 4 236
Hemalini Mehta 3 10 6 58 7 5 238
Allyson Larkin 3 7 8 27 30 7 214
Lozano 4 11 69 39 2 155
Agnieszka Szwajda 5 8 5 54 9 3 181
Sharon Brouwer 5 8 5 40 15 9 219
Clive B. Archer 5 1 25 14 91 8 164
Amanda Abramson Lloyd 5 41 125 6 8 195
M. L. Kowalski 19 22 41 6 145

All Works

Loading papers...

Rankless by CCL
2026